MENU
+Compare
LYRA
Stock ticker: NASDAQ
AS OF
Aug 21, 04:59 PM (EDT)
Price
$7.34
Change
+$0.09 (+1.24%)
Capitalization
12.07M

LYRA Lyra Therapeutics Inc Forecast, Technical & Fundamental Analysis

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients... Show more

LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LYRA with price predictions
Aug 20, 2025

LYRA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for LYRA turned positive on August 08, 2025. Looking at past instances where LYRA's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LYRA's RSI Oscillator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where LYRA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 13, 2025. You may want to consider a long position or call options on LYRA as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LYRA advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .

LYRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 50-day moving average for LYRA moved below the 200-day moving average on August 20, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LYRA entered a downward trend on August 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.440) is normal, around the industry mean (19.342). P/E Ratio (0.000) is within average values for comparable stocks, (50.253). LYRA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.941). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (12.594) is also within normal values, averaging (299.575).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LYRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ES65.711.17
+1.81%
Eversource Energy
GDYN7.85-0.02
-0.25%
Grid Dynamics Holdings
GRNQ1.36-0.02
-1.45%
Greenpro Capital Corp
MRAM5.97-0.09
-1.49%
Everspin Technologies
PTON7.84-0.61
-7.22%
Peloton Interactive

LYRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if LYRA jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-3.01%
EYPT - LYRA
58%
Loosely correlated
-2.56%
VERA - LYRA
54%
Loosely correlated
+1.24%
KYMR - LYRA
53%
Loosely correlated
-2.41%
CLNN - LYRA
39%
Loosely correlated
+5.66%
TBPH - LYRA
35%
Loosely correlated
-1.18%
More

Groups containing LYRA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-3.01%
LYRA
(1 stocks)
97%
Closely correlated
+1.24%